0 XP   0   0   0

Clal Biotechnology Industries Ltd










Financial Health of Clal Biotechnology Industries Ltd




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Clal Biotechnology Industries Ltd
Buy, Hold or Sell?

Should you buy, hold or sell Clal Biotechnology Industries Ltd?

I guess you are interested in Clal Biotechnology Industries Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Clal Biotechnology Industries Ltd

Let's start. I'm going to help you getting a better view of Clal Biotechnology Industries Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Clal Biotechnology Industries Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Clal Biotechnology Industries Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Clal Biotechnology Industries Ltd. The closing price on 2022-11-24 was ILA71.00 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Clal Biotechnology Industries Ltd Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Clal Biotechnology Industries Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Clal Biotechnology Industries Ltd earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that 0.00 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM--281.7%+281.7%
YOY--344.8%+344.8%
5Y--450.1%+450.1%
10Y--541.0%+541.0%
1.1.2. Return on Assets

Shows how efficient Clal Biotechnology Industries Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • 0.0% Return on Assets means that Clal Biotechnology Industries Ltd generated 0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--9.9%+9.9%
TTM--8.9%+8.9%
YOY--9.3%+9.3%
5Y--11.7%+11.7%
10Y--12.7%+12.7%
1.1.3. Return on Equity

Shows how efficient Clal Biotechnology Industries Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • 0.0% Return on Equity means Clal Biotechnology Industries Ltd generated 0.00 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.0%+12.0%
TTM--11.5%+11.5%
YOY--10.8%+10.8%
5Y--14.2%+14.2%
10Y--15.2%+15.2%

1.2. Operating Efficiency of Clal Biotechnology Industries Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Clal Biotechnology Industries Ltd is operating .

  • Measures how much profit Clal Biotechnology Industries Ltd makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM--271.0%+271.0%
YOY--325.9%+325.9%
5Y--454.0%+454.0%
10Y--537.1%+537.1%
1.2.2. Operating Ratio

Measures how efficient Clal Biotechnology Industries Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are 0.00 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
YOY-3.604-3.604
5Y-5.132-5.132
10Y-6.371-6.371

1.3. Liquidity of Clal Biotechnology Industries Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Clal Biotechnology Industries Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.90 means the company has 1.90 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 1.902. The company is able to pay all its short-term debts. +1
  • The TTM is 2.408. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.902TTM2.408-0.506
TTM2.408YOY3.912-1.504
TTM2.4085Y3.817-1.408
5Y3.81710Y3.525+0.292
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9025.117-3.215
TTM2.4085.755-3.347
YOY3.9125.854-1.942
5Y3.8176.511-2.694
10Y3.5256.222-2.697
1.3.2. Quick Ratio

Measures if Clal Biotechnology Industries Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.59 means the company can pay off 0.59 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.592. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.304. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.592TTM0.304+0.287
TTM0.304YOY1.574-1.270
TTM0.3045Y1.712-1.408
5Y1.71210Y1.580+0.132
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5924.284-3.692
TTM0.3044.664-4.360
YOY1.5744.787-3.213
5Y1.7125.218-3.506
10Y1.5805.182-3.602

1.4. Solvency of Clal Biotechnology Industries Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Clal Biotechnology Industries Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Clal Biotechnology Industries Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.26 means that Clal Biotechnology Industries Ltd assets are financed with 25.6% credit (debt) and the remaining percentage (100% - 25.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.256. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.238. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.256TTM0.238+0.018
TTM0.238YOY0.205+0.032
TTM0.2385Y0.205+0.032
5Y0.20510Y0.218-0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2560.278-0.022
TTM0.2380.277-0.039
YOY0.2050.306-0.101
5Y0.2050.367-0.162
10Y0.2180.403-0.185
1.4.2. Debt to Equity Ratio

Measures if Clal Biotechnology Industries Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 76.4% means that company has 0.76 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.764. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.636. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.764TTM0.636+0.128
TTM0.636YOY0.487+0.149
TTM0.6365Y0.538+0.098
5Y0.53810Y0.581-0.042
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7640.315+0.449
TTM0.6360.317+0.319
YOY0.4870.319+0.168
5Y0.5380.403+0.135
10Y0.5810.462+0.119

2. Market Valuation of Clal Biotechnology Industries Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Clal Biotechnology Industries Ltd generates.

  • Above 15 is considered overpriced but always compare Clal Biotechnology Industries Ltd to the Biotechnology industry mean.
  • A PE ratio of 0.00 means the investor is paying 0.00 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Clal Biotechnology Industries Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--9.792+9.792
TTM--16.243+16.243
YOY--20.876+20.876
5Y--16.665+16.665
10Y--14.732+14.732

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Clal Biotechnology Industries Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 38.29 means the investor is paying 38.29 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Clal Biotechnology Industries Ltd:

  • The EOD is 33.317. Seems overpriced? -1
  • The MRQ is 38.291. Seems overpriced? -1
  • The TTM is 51.499. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD33.317MRQ38.291-4.974
MRQ38.291TTM51.499-13.208
TTM51.499YOY64.580-13.081
TTM51.4995Y51.208+0.291
5Y51.20810Y52.612-1.403
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD33.3171.835+31.482
MRQ38.2912.006+36.285
TTM51.4992.774+48.725
YOY64.5803.453+61.127
5Y51.2082.713+48.495
10Y52.6122.402+50.210
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Clal Biotechnology Industries Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.088-0.144+63%-0.027-69%-0.110+25%-0.315+259%
Book Value Growth---0.069-0.064-7%-0.024-66%-0.043-38%-0.103+49%
Book Value Per Share--2.1312.240-5%2.886-26%3.649-42%4.168-49%
Book Value Per Share Growth---0.041-0.065+58%-0.016-61%-0.043+4%-0.103+151%
Current Ratio--1.9022.408-21%3.912-51%3.817-50%3.525-46%
Debt To Asset Ratio--0.2560.238+8%0.205+25%0.205+25%0.218+17%
Debt To Equity Ratio--0.7640.636+20%0.487+57%0.538+42%0.581+32%
Dividend Per Share----0%-0%-0%-0%
Eps----0%-0%-0%-0%
Gross Profit Margin----0%-0%-0%-0%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio33.317-15%38.29151.499-26%64.580-41%51.208-25%52.612-27%
Pe Ratio----0%-0%-0%-0%
Price Per Share71.000-15%81.600115.825-30%185.483-56%187.791-57%222.152-63%
Price To Total Gains Ratio-808.429+13%-929.124-225.536-76%-602.918-35%-187.499-80%-257.539-72%
Quick Ratio--0.5920.304+94%1.574-62%1.712-65%1.580-63%
Return On Assets----0%-0%-0%-0%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share---0.088-0.144+63%-0.027-69%-0.110+25%-0.315+259%
Total Gains Per Share Growth---2.3500.505-566%-0.872-63%0.308-862%1.547-252%
Usd Book Value--334245000.000355856500.000-6%461925000.000-28%577075400.000-42%657630041.667-49%
Usd Book Value Change Per Share----0%-0%-0%-0%
Usd Book Value Per Share----0%-0%-0%-0%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps----0%-0%-0%-0%
Usd Price Per Share71.000+100%--0%-0%-0%-0%
Usd Profit----0%-0%-0%-0%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share----0%-0%-0%-0%
 EOD+4 -0MRQTTM+6 -8YOY+2 -125Y+5 -910Y+6 -8

3.2. Fundamental Score

Let's check the fundamental score of Clal Biotechnology Industries Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Book Ratio (EOD)Between0-133.317
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.592
Current Ratio (MRQ)Greater than11.902
Debt to Asset Ratio (MRQ)Less than10.256
Debt to Equity Ratio (MRQ)Less than10.764
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total3/9 (33.3%)

3.3. Technical Score

Let's check the technical score of Clal Biotechnology Industries Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.305
Ma 20Greater thanMa 5073.340
Ma 50Greater thanMa 10079.054
Ma 100Greater thanMa 20086.578
OpenGreater thanClose70.900
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in ILS. All numbers in thousands.

Summary
Total Assets449,302
Total Liabilities115,057
Total Stockholder Equity150,617
 As reported
Total Liabilities 115,057
Total Stockholder Equity+ 150,617
Total Assets = 449,302

Assets

Total Assets449,302
Total Current Assets72,428
Long-term Assets72,428
Total Current Assets
Cash And Cash Equivalents 39,408
Short-term Investments 9,374
Net Receivables 13,155
Inventory 6,970
Other Current Assets 3,521
Total Current Assets  (as reported)72,428
Total Current Assets  (calculated)72,428
+/-0
Long-term Assets
Property Plant Equipment 18,569
Other Assets 2,285
Long-term Assets  (as reported)376,874
Long-term Assets  (calculated)20,854
+/- 356,020

Liabilities & Shareholders' Equity

Total Current Liabilities38,085
Long-term Liabilities76,972
Total Stockholder Equity150,617
Total Current Liabilities
Accounts payable 17,065
Other Current Liabilities 21,020
Total Current Liabilities  (as reported)38,085
Total Current Liabilities  (calculated)38,085
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt8,476
Other Liabilities 29,791
Long-term Liabilities Other 215
Long-term Liabilities  (as reported)76,972
Long-term Liabilities  (calculated)38,482
+/- 38,490
Total Stockholder Equity
Common Stock1,613
Other Stockholders Equity 137,161
Total Stockholder Equity (as reported)150,617
Total Stockholder Equity (calculated)138,774
+/- 11,843
Other
Capital Stock1,613
Common Stock Shares Outstanding 156,846
Net Invested Capital 150,617
Net Tangible Assets -82,609
Net Working Capital 34,343



Balance Sheet

Currency in ILS. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-03-312007-12-312007-09-30
> Total Assets 
449,037
442,461
0
425,921
454,291
473,661
959,936
936,321
896,329
1,028,960
1,363,970
1,320,592
1,362,878
1,695,034
1,250,536
1,193,808
1,204,184
1,217,925
1,749,349
2,293,023
2,373,718
2,110,317
1,921,343
2,109,944
2,525,384
2,129,444
1,687,603
1,706,770
1,568,453
1,575,689
1,532,772
1,440,775
1,416,599
1,330,702
1,118,710
1,046,705
990,938
1,087,306
1,034,340
1,011,190
999,911
996,075
1,016,081
978,795
720,251
662,689
616,965
577,459
568,193
550,140
614,031
626,623
533,904
504,990
444,918
466,614
449,302
449,302466,614444,918504,990533,904626,623614,031550,140568,193577,459616,965662,689720,251978,7951,016,081996,075999,9111,011,1901,034,3401,087,306990,9381,046,7051,118,7101,330,7021,416,5991,440,7751,532,7721,575,6891,568,4531,706,7701,687,6032,129,4442,525,3842,109,9441,921,3432,110,3172,373,7182,293,0231,749,3491,217,9251,204,1841,193,8081,250,5361,695,0341,362,8781,320,5921,363,9701,028,960896,329936,321959,936473,661454,291425,9210442,461449,037
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
191,351
153,037
128,367
215,111
185,228
160,674
145,534
138,525
139,113
125,738
173,578
148,672
137,355
137,660
124,173
122,379
211,094
169,390
106,147
111,432
77,610
89,155
72,428
72,42889,15577,610111,432106,147169,390211,094122,379124,173137,660137,355148,672173,578125,738139,113138,525145,534160,674185,228215,111128,367153,037191,3510000000000000000000000000000000000
       Cash And Cash Equivalents 
0
257,386
0
214,894
0
160,917
238,963
190,105
167,944
148,826
87,129
99,797
178,902
57,106
43,061
44,274
42,046
43,510
50,152
33,290
148,092
139,591
83,429
334,078
187,431
134,542
191,704
176,924
121,801
186,607
240,292
79,662
79,487
64,338
165,630
53,443
46,631
138,596
164,247
58,736
38,399
38,232
40,366
42,475
100,762
37,440
37,551
39,010
58,612
53,471
68,157
133,337
80,078
84,256
53,049
70,476
39,408
39,40870,47653,04984,25680,078133,33768,15753,47158,61239,01037,55137,440100,76242,47540,36638,23238,39958,736164,247138,59646,63153,443165,63064,33879,48779,662240,292186,607121,801176,924191,704134,542187,431334,07883,429139,591148,09233,29050,15243,51042,04644,27443,06157,106178,90299,79787,129148,826167,944190,105238,963160,9170214,8940257,3860
       Short-term Investments 
0
23,157
0
0
0
52,063
39,916
55,734
21,177
33,883
26,894
15,630
135
30,443
20,014
0
2,108
742
5,840
10,554
0
0
8,679
2,193
181,398
200,011
158,660
173,891
159,259
102,721
15,813
125,604
105,484
109,111
5,392
77,964
64,796
54,496
830
81,356
78,511
75,699
63,404
52,239
50,287
87,644
76,979
76,670
43,108
49,144
118,338
593
592
591
0
588
9,374
9,3745880591592593118,33849,14443,10876,67076,97987,64450,28752,23963,40475,69978,51181,35683054,49664,79677,9645,392109,111105,484125,60415,813102,721159,259173,891158,660200,011181,3982,1938,6790010,5545,8407422,108020,01430,44313515,63026,89433,88321,17755,73439,91652,06300023,1570
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,415
17,402
13,012
16,315
13,612
13,483
21,796
18,276
27,450
25,676
17,055
18,645
14,445
14,835
9,579
9,119
9,949
17,179
6,732
6,543
7,436
7,459
13,155
13,1557,4597,4366,5436,73217,1799,9499,1199,57914,83514,44518,64517,05525,67627,45018,27621,79613,48313,61216,31513,01217,40216,4150000000000000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
666
629
0
0
0
0
0
0
870
0
0
0
1,306
0
6,172
4,435
7,630
13,380
14,189
15,998
10,709
4,535
3,521
3,5214,53510,70915,99814,18913,3807,6304,4356,17201,3060008700000006296660000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
853,057
546,673
514,017
479,610
439,799
444,020
427,761
402,937
457,233
427,757
393,558
367,308
377,459
376,874
376,874377,459367,308393,558427,757457,233402,937427,761444,020439,799479,610514,017546,673853,0570000000000000000000000000000000000000000000
       Property Plant Equipment 
4,235
2,913
0
3,308
0
4,440
6,367
6,250
6,025
6,461
3,385
3,387
3,131
3,127
2,684
2,569
2,726
2,779
7,293
11,652
11,881
11,439
10,809
10,337
10,168
10,427
10,222
13,201
14,918
16,134
17,077
17,304
17,028
16,919
16,536
15,590
14,198
15,175
14,854
14,407
15,553
8,304
7,786
17,664
16,948
16,189
16,318
16,871
15,983
16,446
14,943
15,311
20,052
19,232
18,064
17,839
18,569
18,56917,83918,06419,23220,05215,31114,94316,44615,98316,87116,31816,18916,94817,6647,7868,30415,55314,40714,85415,17514,19815,59016,53616,91917,02817,30417,07716,13414,91813,20110,22210,42710,16810,33710,80911,43911,88111,6527,2932,7792,7262,5692,6843,1273,1313,3873,3856,4616,0256,2506,3674,44003,30802,9134,235
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
95,665
0
0
0
100,588
0
0
0
114,860
0
0
0
115,263
0
0
0
12,868
0
0
0
11,613
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000011,61300012,868000115,263000114,860000100,58800095,665000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
164,841
174,810
207,624
211,108
202,376
198,526
182,265
208,026
208,961
202,914
195,432
167,612
0
0
0
0
0
0
0
0
0
0
0
00000000000167,612195,432202,914208,961208,026182,265198,526202,376211,108207,624174,810164,8410000000000000000000000000000000000
       Intangible Assets 
0
47,678
0
44,925
0
46,876
478,488
481,679
470,475
486,956
446,530
440,204
432,912
467,541
83,201
82,217
69,642
149,877
1,045,834
1,679,232
1,690,322
1,652,252
1,491,116
1,541,443
1,390,833
1,483,348
1,051,521
1,073,954
1,016,923
1,051,306
1,035,753
1,000,052
1,016,174
955,174
741,543
699,451
636,977
640,258
626,342
632,095
641,433
623,276
641,062
618,265
325,430
312,369
304,694
0
0
0
241,048
0
0
0
215,779
0
0
00215,779000241,048000304,694312,369325,430618,265641,062623,276641,433632,095626,342640,258636,977699,451741,543955,1741,016,1741,000,0521,035,7531,051,3061,016,9231,073,9541,051,5211,483,3481,390,8331,541,4431,491,1161,652,2521,690,3221,679,2321,045,834149,87769,64282,21783,201467,541432,912440,204446,530486,956470,475481,679478,48846,876044,925047,6780
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
853,057
546,673
514,017
479,610
0
0
0
0
0
0
0
0
0
0
0000000000479,610514,017546,673853,0570000000000000000000000000000000000000000000
> Total Liabilities 
153,638
82,592
0
151,469
147,359
124,425
154,285
153,409
153,628
172,281
138,200
146,958
148,825
174,239
142,006
139,730
148,884
167,506
354,193
482,126
495,275
604,133
540,451
480,574
425,391
425,342
428,444
439,170
397,219
411,922
440,305
392,415
411,335
389,164
366,215
335,470
313,048
244,701
226,144
231,875
202,856
185,872
148,462
155,293
133,657
117,747
119,119
118,796
114,351
121,471
100,240
145,659
109,628
111,645
106,549
109,147
115,057
115,057109,147106,549111,645109,628145,659100,240121,471114,351118,796119,119117,747133,657155,293148,462185,872202,856231,875226,144244,701313,048335,470366,215389,164411,335392,415440,305411,922397,219439,170428,444425,342425,391480,574540,451604,133495,275482,126354,193167,506148,884139,730142,006174,239148,825146,958138,200172,281153,628153,409154,285124,425147,359151,469082,592153,638
   > Total Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,277
61,824
42,938
45,448
31,182
36,166
42,500
27,396
23,681
34,237
44,187
39,087
41,052
40,583
36,108
44,797
28,279
73,728
33,653
34,654
35,651
38,125
38,085
38,08538,12535,65134,65433,65373,72828,27944,79736,10840,58341,05239,08744,18734,23723,68127,39642,50036,16631,18245,44842,93861,82468,2770000000000000000000000000000000000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
78,306
74,457
74,016
77,261
71,875
72,698
85,386
0
0
0
0
0
10,944
0
0
0
0
0
0
0
0
0
0
000000000010,9440000085,38672,69871,87577,26174,01674,45778,3060000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
78,306
74,457
74,016
77,261
71,875
72,698
85,386
0
0
0
0
0
10,944
0
0
0
0
0
0
0
0
0
0
000000000010,9440000085,38672,69871,87577,26174,01674,45778,3060000000000000000000000000000000000
       Accounts payable 
0
7,232
0
17,226
0
12,585
12,960
8,981
12,722
17,771
14,200
18,551
18,977
24,001
22,174
19,306
16,937
18,605
15,654
15,248
20,624
22,639
22,359
23,720
8,423
6,344
9,844
12,715
13,211
10,824
14,782
14,950
9,229
6,779
8,507
15,444
10,389
12,515
7,975
13,954
15,900
13,168
10,567
10,734
14,721
10,342
14,104
12,205
8,400
10,857
9,622
10,861
13,238
11,981
14,600
17,859
17,065
17,06517,85914,60011,98113,23810,8619,62210,8578,40012,20514,10410,34214,72110,73410,56713,16815,90013,9547,97512,51510,38915,4448,5076,7799,22914,95014,78210,82413,21112,7159,8446,3448,42323,72022,35922,63920,62415,24815,65418,60516,93719,30622,17424,00118,97718,55114,20017,77112,7228,98112,96012,585017,22607,2320
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,121
46,380
32,549
32,933
9,730
22,212
19,168
14,228
3,943
23,503
29,466
28,745
2,950
28,378
27,708
33,940
3,680
62,867
20,415
22,673
4,091
20,266
21,020
21,02020,2664,09122,67320,41562,8673,68033,94027,70828,3782,95028,74529,46623,5033,94314,22819,16822,2129,73032,93332,54946,38035,1210000000000000000000000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
121,056
89,470
78,660
78,067
78,213
78,243
76,674
71,961
71,931
75,975
76,991
70,898
71,022
76,972
76,97271,02270,89876,99175,97571,93171,96176,67478,24378,21378,06778,66089,470121,0560000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-78,306
-74,457
-74,016
-77,261
-71,875
-72,698
-85,386
0
0
7,800
7,458
7,174
-1,983
6,909
6,634
6,822
7,735
5,510
10,407
9,857
11,682
8,782
8,476
8,4768,78211,6829,85710,4075,5107,7356,8226,6346,909-1,9837,1747,4587,80000-85,386-72,698-71,875-77,261-74,016-74,457-78,3060000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,881
28,756
70,387
22,677
28,379
28,785
26,144
21,879
26,566
26,328
26,048
370
288
215
21528837026,04826,32826,56621,87926,14428,78528,37922,67770,38728,75627,8810000000000000000000000000000000000000000000
> Total Stockholder Equity
295,399
331,214
359,869
254,317
286,832
331,674
550,137
532,165
482,238
577,127
991,077
947,473
993,357
1,287,262
1,079,341
1,023,885
1,034,584
1,000,526
953,968
943,702
1,011,768
932,210
866,109
845,685
1,344,110
916,793
679,205
678,021
618,150
602,445
552,896
515,122
489,927
458,518
363,074
346,486
356,790
386,347
382,115
360,087
344,529
382,614
398,898
377,406
292,992
260,221
223,599
206,360
216,562
198,522
306,346
275,506
228,429
208,239
172,594
174,283
150,617
150,617174,283172,594208,239228,429275,506306,346198,522216,562206,360223,599260,221292,992377,406398,898382,614344,529360,087382,115386,347356,790346,486363,074458,518489,927515,122552,896602,445618,150678,021679,205916,7931,344,110845,685866,109932,2101,011,768943,702953,9681,000,5261,034,5841,023,8851,079,3411,287,262993,357947,473991,077577,127482,238532,165550,137331,674286,832254,317359,869331,214295,399
   Common Stock
295,399
861
0
861
286,832
861
905
915
915
945
982
982
1,020
1,020
1,020
1,020
1,020
1,020
1,020
1,020
1,210
1,210
1,210
1,227
1,343
1,343
1,343
1,362
1,362
1,362
1,362
1,362
1,362
1,362
1,362
1,422
1,497
1,565
1,565
1,565
1,565
1,613
1,613
1,613
1,613
1,613
1,613
1,613
1,613
1,613
1,613
1,613
1,613
1,613
1,613
1,613
1,613
1,6131,6131,6131,6131,6131,6131,6131,6131,6131,6131,6131,6131,6131,6131,6131,6131,5651,5651,5651,5651,4971,4221,3621,3621,3621,3621,3621,3621,3621,3621,3431,3431,3431,2271,2101,2101,2101,0201,0201,0201,0201,0201,0201,0201,020982982945915915905861286,8328610861295,399
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
163,376
146,526
138,769
134,930
148,110
134,111
148,072
163,628
174,487
165,801
159,491
154,530
152,049
137,597
133,799
131,065
123,721
131,887
129,455
128,242
125,291
125,890
137,161
137,161125,890125,291128,242129,455131,887123,721131,065133,799137,597152,049154,530159,491165,801174,487163,628148,072134,111148,110134,930138,769146,526163,3760000000000000000000000000000000000



Balance Sheet

Currency in ILS. All numbers in thousands.




Cash Flow

Currency in ILS. All numbers in thousands.




Income Statement

Currency in ILS. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue76,961
Cost of Revenue-66,241
Gross Profit10,72010,720
 
Operating Income (+$)
Gross Profit10,720
Operating Expense-143,710
Operating Income-66,749-132,990
 
Operating Expense (+$)
Research Development33,073
Selling General Administrative20,017
Selling And Marketing Expenses-
Operating Expense143,71053,090
 
Net Interest Income (+$)
Interest Income37
Interest Expense-7,428
Net Interest Income-7,817-7,391
 
Pretax Income (+$)
Operating Income-66,749
Net Interest Income-7,817
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-128,123-66,749
EBIT - interestExpense = -74,177
-89,494
-82,155
Interest Expense7,428
Earnings Before Interest and Taxes (ebit)-66,749-120,695
Earnings Before Interest and Taxes (ebitda)-98,184
 
After tax Income (+$)
Income Before Tax-128,123
Tax Provision-89
Net Income From Continuing Ops-128,212-128,212
Net Income-89,583
Net Income Applicable To Common Shares-89,583
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-7,817
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
YMH23-CBT.COMM
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of YMH23-CBT.COMM.

YMH23-CBT.COMM Daily Candlestick Chart
YMZ22-CBT.COMM
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of YMZ22-CBT.COMM.

YMZ22-CBT.COMM Daily Candlestick Chart
NGJ23-NYM.COMM
5 minutes ago

I found you a Death Cross on the daily chart of NGJ23-NYM.COMM.

NGJ23-NYM.COMM Daily Candlestick Chart
KEZ23-CBT.COMM
6 minutes ago

I found you a Death Cross on the daily chart of KEZ23-CBT.COMM.

KEZ23-CBT.COMM Daily Candlestick Chart
YM.COMM
8 minutes ago

I found you a Golden Cross on the daily chart of YM.COMM.

YM.COMM Daily Candlestick Chart
US30.COMM
8 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of US30.COMM.

US30.COMM Daily Candlestick Chart
UK100.COMM
8 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of UK100.COMM.

UK100.COMM Daily Candlestick Chart
PL.COMM
8 minutes ago

I found you a Golden Cross on the daily chart of PL.COMM.

PL.COMM Daily Candlestick Chart
CSX.V
10 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of CSX.V.

CSX.V Daily Candlestick Chart
XGI.TO
10 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XGI.TO.

XGI.TO Daily Candlestick Chart
FBGO.TO
10 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FBGO.TO.

FBGO.TO Daily Candlestick Chart
ZUK.WAR
13 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of ZUK.WAR.

ZUK.WAR Daily Candlestick Chart
BAH.WAR
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BAH.WAR.

BAH.WAR Daily Candlestick Chart
VOX.WAR
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOX.WAR.

VOX.WAR Daily Candlestick Chart
PCO.WAR
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PCO.WAR.

PCO.WAR Daily Candlestick Chart
WTN.WAR
15 minutes ago

I found you a Golden Cross on the daily chart of WTN.WAR.

WTN.WAR Daily Candlestick Chart
RMATCH.CO
16 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of RMATCH.CO.

RMATCH.CO Daily Candlestick Chart
MBK.WAR
16 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of MBK.WAR.

MBK.WAR Daily Candlestick Chart
04Q.XETRA
17 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 04Q.XETRA.

04Q.XETRA Daily Candlestick Chart
HBIS.PINK
23 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of HBIS.PINK.

HBIS.PINK Daily Candlestick Chart
KLEE-B.CO
39 minutes ago

I found you a Golden Cross on the daily chart of KLEE-B.CO.

KLEE-B.CO Daily Candlestick Chart